Patents for C12R 1 - Micro-organisms (92,025) |
---|
03/21/2002 | WO2002022080A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
03/21/2002 | WO2001087982A3 Immunotoxin fusion proteins and means for expression thereof |
03/21/2002 | WO2001068818A3 Hcv ns2/3 fragments and uses thereof |
03/21/2002 | WO2001062066A3 For higher basidiomycetes mushrooms grown (as one cell biomass) in submerged culture |
03/21/2002 | WO2001047952A3 Insecticidal proteins from bacillus thuringiensis |
03/21/2002 | US20020035249 Production of exopolysaccharides unattached to the surface of bacterial cells |
03/21/2002 | US20020035240 Novel mammalian cell cycle protein |
03/21/2002 | US20020035081 Nucleic acid encoding a polypeptide of the virus' core protein having altered carboxyterminus, for reducing replication of a wild type hepadnavirus, by a dominant negative mechanism |
03/21/2002 | US20020034820 Sebocytes, sebocyte-cell line and uses thereof |
03/21/2002 | US20020034816 Genetically engineered gram-positive bacterium for the generation of ethyl alcohol |
03/21/2002 | US20020034797 Modified modular pks with retained scaffold |
03/21/2002 | US20020034793 L-arginine producing escherichia coli and method of producing L-arginine |
03/21/2002 | US20020034779 Novel argS |
03/21/2002 | US20020034776 Genetically engineering enzymatic proteins; transform eschericha, generate mutations, transmit mutation to another microoganism and detect enzymatic activity, recover microorganism with adjusted enzymatic activity |
03/21/2002 | US20020034509 Methods and compositions for ameliorating the symptoms of sepsis |
03/21/2002 | US20020034504 Suppressor cells for prevention and treatment of immune responses in transplantation |
03/21/2002 | US20020033366 Method for water denitrification |
03/21/2002 | CA2422882A1 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
03/21/2002 | CA2422466A1 Enzymatic resolution of aryl- and thio-substituted acids |
03/21/2002 | CA2422060A1 Compositions comprising mixtures of human cytokines and methods of producing the same |
03/21/2002 | CA2357469A1 Process for producing non-proteinogenic l-amino acids by fermentation |
03/20/2002 | EP1188837A1 Process for preparing N-substituted 4-hydroxypiperidines by enzymatic hydroxylation |
03/20/2002 | EP1188836A2 Production method of polyester containing epoxy group in side chain and production method of crosslinked polymer |
03/20/2002 | EP1188822A1 L-amino acid-producing bacteria and process for producing l-amino acid |
03/20/2002 | EP1188821A1 Carrier for animal cell culture comprising organ tissue slice and animal cell culture method and transplantation method with the use of the carrier |
03/20/2002 | EP1188383A1 Method for production of arachidonic acid |
03/20/2002 | EP1187925A1 Pectate lyase fusion for expression and secretion of polypeptides |
03/20/2002 | EP1187922A2 Pesticidal proteins |
03/20/2002 | EP1187852A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
03/20/2002 | EP1187842A1 Human tumor necrosis factor receptor tr10 |
03/20/2002 | EP0839209B1 Method for preparing pure lactic acid |
03/20/2002 | EP0628077B1 Humanised antibodies directed against a33 antigen |
03/20/2002 | EP0591385B1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
03/20/2002 | EP0418316B1 Platelet-specific chimeric immunoglobulin |
03/20/2002 | CN1341148A Nucleic acid molecules encoding alternansucrase |
03/20/2002 | CN1340628A Improved method for biological production of carotenoid and its used biomaterial |
03/19/2002 | USRE37596 Hybridoma cell line which produces the monoclonal antibody bw sclc-1 having the deposit number ecacc no. 90022110. |
03/19/2002 | US6359126 Antibodies to αvβ3 integrin |
03/19/2002 | US6359115 Human receptor tyrosine kinase, KDR |
03/19/2002 | US6358969 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants |
03/19/2002 | US6358732 Nucleotide sequences preferential polypeptides for use in the treatment of defects in central nervous system |
03/19/2002 | US6358727 Nucleotide sequences coding binding protein for use in treatment and prevention of infections |
03/19/2002 | US6358715 Production of ascorbic acid |
03/19/2002 | US6358704 M protein |
03/19/2002 | US6358703 Expression system for factor VIII |
03/19/2002 | US6358700 Using fluorescent dye |
03/19/2002 | US6358694 Culturing prostaglandin receptor expressing cells in the presence of a test compound; measure the modulating affects of the compound that interacts with the recombinant receptor and compare the affects with a control host cell |
03/19/2002 | US6358509 Administering to animal a polypeptide wherein animal produces antibodies against polypeptide, antibodies being able to specifically bind to human il-4 and are able to inhibit binding of human il-4 to cellular receptors |
03/19/2002 | CA2101076C Glycosphingolipids |
03/19/2002 | CA2099779C Mixed specificity fusion proteins |
03/19/2002 | CA2008390C Mutants of human antithrombin iii |
03/19/2002 | CA1341348C Human tumor necrosis factor |
03/14/2002 | WO2002020829A1 Culture medium and method for identifying gram-negative microorganisms |
03/14/2002 | WO2002020817A1 A method of producing fr901228 |
03/14/2002 | WO2002020815A2 Production of cyclic terpenoids |
03/14/2002 | WO2002020728A2 High growth methanotrophic bacterial strain methylomonas 16a |
03/14/2002 | WO2002020714A1 Method and apparatus for peeling cells from vital tissue |
03/14/2002 | WO2002020560A1 Novel human cancer/testis antigen and gene thereof |
03/14/2002 | WO2002000845A9 Enhanced flavour production in or relating to food by cultivation of various food-grade micro-organisms |
03/14/2002 | WO2001081581A3 Compositions and methods for the therapy and diagnosis of acne vulgaris |
03/14/2002 | WO2001059126A3 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
03/14/2002 | WO2001048162A3 Method for the production of vitamin a |
03/14/2002 | WO2001034092A3 A novel medium for the production of betacarotene and other carotenoids from dunaliella salina (arl 5) and a strain of dunaliella salina for production of carotenes using the novel media |
03/14/2002 | US20020032915 Detecting size defect in animal infants; obtain tissue biopsy, monitor expression of somatomedins in sample, amplified somatomedin concentration indicates potential size defect in animals |
03/14/2002 | US20020031831 Plasmid for use in vaccination and gene therapy |
03/14/2002 | US20020031806 Purified human erythropoietin receptor protein fragment and antibodies derived therefrom |
03/14/2002 | US20020031798 Antibody recognizing human 25-hydroxyvitamin D3-1a-hydroxylase |
03/14/2002 | US20020031760 Nucleotide sequences for use in the detection of preferential microorganism |
03/14/2002 | US20020031503 Lactobacillus rhamnosus HN001 and HN 067, Lactobacillus acidophilus HN017, and Bifidobacterium lactis HN019 |
03/14/2002 | US20020031499 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
03/14/2002 | CA2422114A1 Novel human cancer/testis antigen and gene thereof |
03/14/2002 | CA2421436A1 Culture medium and method for identifying gram-negative microorganisms |
03/14/2002 | CA2419599A1 A biological fertilizer based on yeasts |
03/14/2002 | CA2417246A1 Production of cyclic terpenoids |
03/14/2002 | CA2416858A1 High growth methanotrophic bacterial strain methylomonas 16a |
03/13/2002 | EP1186664A2 Process for producing a fermentation product |
03/13/2002 | EP1186660A2 Method for obtaining DNA, RNA, peptides, polypeptides or proteins by means of a DNA-recombination technique |
03/13/2002 | EP1186617A1 Novel recombinant antibody, amino acid sequences of cdrs thereof and genes encoding the same |
03/13/2002 | EP1186301A2 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
03/13/2002 | EP1185691A1 Neisseria genomic sequences and methods of their use |
03/13/2002 | EP1185672A2 Recombinant hosts suitable for simultaneous saccharification and fermentation |
03/13/2002 | EP1185667A2 Mutant 1,3-propanediol dehydrogenase |
03/13/2002 | EP1185631A1 Novel endo-beta-1,4-glucanases |
03/13/2002 | EP1185620A2 Spheroid preparation |
03/13/2002 | EP1185618A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
03/13/2002 | EP1185258A1 Therapeutic uses for nitric oxide inhibitors |
03/13/2002 | EP0858514B1 Improved is6110 based molecular detection of mycobacterium tuberculosis |
03/13/2002 | EP0721342B1 Polypeptides of the semaphorin gene family |
03/13/2002 | EP0675954B1 Deblocking the common pathway of aromatic amino acid synthesis |
03/13/2002 | CN1340105A Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells |
03/13/2002 | CN1340097A Enzymatic production of difructose dianhydride IV from sucrose and relevant enzymes and genes coding for them |
03/12/2002 | US6356845 Crystallization and structure determination of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (S. aureus MurB) |
03/12/2002 | US6355475 Generating fungal culture; obtain fungus, incculate and propagate fungus harvesting the culture |
03/12/2002 | US6355472 Method for producing nucleoside-5′-phosphate ester |
03/12/2002 | US6355464 M. tuberculosis RNA polymerase alpha subunit |
03/12/2002 | US6355463 UDP-N-acetylenolpyruvylglucosamine reductase |
03/12/2002 | US6355444 Detecting cancer marker in sample; obtain hybridoma sample, incubate with antibody, detect bound antibody |
03/12/2002 | US6355440 Detecting cell growth factors in sample; mix target sample with preferential receptors, detect binding, bound receptor indicates presence of cell growth factor in sample |
03/12/2002 | US6355412 Methods and compositions for directed cloning and subcloning using homologous recombination |
03/12/2002 | US6355411 Virulence-associated nucleic acid sequences and uses thereof |